Guiyang Runfeng Pharmaceutical

Guiyang Runfeng Pharmaceutical is a China-based pharmaceutical company and a wholly-owned subsidiary of Guizhou Yibai Pharmaceutical. Established in 1995, the company focuses on the manufacturing and distribution of a wide range of pharmaceutical products, including traditional Chinese medicines and generic chemical drugs. Its product portfolio primarily targets cardiovascular and cerebrovascular diseases, with key offerings such as Ginkgo Biloba capsules and Compound Salvia tablets. The company maintains modern production lines that are GMP-certified, ensuring high-quality standards for its capsules, tablets, and granules. Guiyang Runfeng plays a strategic role in the supply chain of its parent company, leveraging regional resources in Guizhou province.